NewAmsterdam Pharma Company NV Overview
NewAmsterdam Pharma Company NV Target Price
Analysts' 12-month price predictions for NAMS.
Get informed when a big investor buys or sells
+ FollowShare Price
$34.83
Average Target Price
$51.00
46.4% upside
46.4% upside1 analysts in the last 4 months
High: $51 | Low: $51
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-30 | RBC Capital | $51 | 46.4% upside |  |
| 2026-02-19 | Guggenheim | $45 | 29.2% upside | |
| 2026-01-21 | RBC Capital | $47 | 34.9% upside | |
| 2026-01-06 | Leerink PartnersRoanna Ruiz | $55 | 57.9% upside | |
| 2025-12-02 | Goldman Sachs | $37 | 6.2% upside | |
| 2025-10-20 | H.C. WainwrightJoseph Pantginis | $52 | 49.3% upside | |
| 2025-08-25 | Wells Fargo | $45 | 29.2% upside | |
| 2025-03-03 | UBS | $41 | 17.7% upside | |
| 2024-12-30 | H.C. WainwrightEd Arce | $48 | 37.8% upside | |
| 2024-11-20 | Leerink PartnersRoanna Ruiz | $45 | 29.2% upside | |
| 2024-09-23 | Piper SandlerYasmeen Rahimi | $37 | 6.2% upside | |
| 2024-08-28 | NeedhamSerge Belanger | $36 | 3.4% upside | |